Evidence map›Paper›PMID 26875071›Full record

ArticleJournal of the American College of Surgeons2016

Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic Lymphadenectomy.

Lesly A Dossett, Nicholas B Castner, Julio M Pow-Sang, Andrea M Abbott, Vernon K Sondak, Amod A Sarnaik, Jonathan S Zager

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of the American College of Surgeons, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Observational
  3. Combined robotic inguinal and iliac-obturator lymphadenectomy for stage III skin cancers: Surgical technique and preliminary results.The international journal of medical robotics + computer assisted surgery : MRCAS · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lesly A DossettDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Nicholas B CastnerDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Julio M Pow-SangDepartment of Genito-Urinary Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Andrea M AbbottDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Vernon K SondakDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Amod A SarnaikDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL.
Jonathan S ZagerDepartment of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: jonathan.zager@moffitt.org.
Moffitt Cancer Center · US

Funding

Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic MelanomaK23CA178083 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SARNAIK, AMOD · 2013 to 2017
$826k
NCI NIH HHS 5K23CA178083-02NCI NIH HHS K23 CA178083
6 · The paper itself

Abstract

backgroundIn the absence of iliac or obturator nodal involvement, the role of pelvic lymphadenectomy (PLND) for melanoma is controversial, but for select patients, long-term survival can be achieved with the combination of superficial inguinal (inguinofemoral) and PLND. Open PLND (oPLND) is often limited in visual exposure and can be associated with considerable postoperative pain. Robotic PLND (rPLND) is a minimally invasive technique that provides excellent visualization of the iliac and obturator nodes. Outcomes comparing the open and robotic techniques have not been reported previously for patients with melanoma. STUDY

designWe reviewed our experience with rPLND for melanoma and compared clinical and pathologic results with oPLND. We evaluated operative times, nodal yield, and short-term oncologic outcomes.

resultsThirteen rPLND (2013 to 2015) (15 attempted, 87% success rate) and 25 oPLND (2010 to 2015) consecutive cases were completed. Pelvic lymphadenectomy was combined with an open inguinofemoral dissection in 8 of 13 (62%) robotic and 17 of 25 (68%) open cases. Median length of stay was shorter in the rPLND group, with 1.0 vs 3.5 days for pelvic-only cases (p < 0.001) and 2.5 vs 4.0 days (p < 0.001) for combined ilioinguinal cases. Median operative time (227 vs 230 minutes; p = 0.96) and nodal yield (11 vs 10 nodes; p = 0.53) were not different between rPLND and oPLND.

conclusionsRobotic PLND offers a safe, effective, minimally invasive approach to resect the pelvic lymph nodes in patients with melanoma, with no significant difference in nodal yield or operative times, but a shorter length of stay compared with oPLND.

Indexed as

LaparoscopyLymph Node ExcisionRobotic Surgical ProceduresAdultAgedFemaleHumansLength of StayMaleMelanomaMiddle AgedOperative TimePelvisRetrospective StudiesSkin NeoplasmsTreatment Outcome

Identifiers

PMID26875071
PMCPMC4871144
OpenAlexW2236164377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.